1-[2-[(Methylsulfonyl)-amino]ethyl]-4-piperidinyl]methyl 1-methyl-1H-indole-3-carboxylate
≥98% (HPLC)
- Product Code: 64766
CAS:
144625-51-4
| Molecular Weight: | 393.50 g./mol | Molecular Formula: | C₁₉H₂₇N₃O₄S |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00912901 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry, particularly in the development of potential therapeutic agents. Its structure suggests it may interact with specific biological targets, such as receptors or enzymes, making it a candidate for drug discovery efforts. It could be explored for its potential in treating neurological disorders, given the presence of the indole moiety, which is often associated with activity in the central nervous system. Additionally, the sulfonyl and piperidinyl groups may contribute to its pharmacokinetic properties, enhancing its bioavailability or stability. Researchers may investigate its efficacy in modulating specific pathways or as a lead compound for further optimization in drug development programs.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | ฿8,865.00 |
+
-
|
1-[2-[(Methylsulfonyl)-amino]ethyl]-4-piperidinyl]methyl 1-methyl-1H-indole-3-carboxylate
This compound is primarily utilized in the field of medicinal chemistry, particularly in the development of potential therapeutic agents. Its structure suggests it may interact with specific biological targets, such as receptors or enzymes, making it a candidate for drug discovery efforts. It could be explored for its potential in treating neurological disorders, given the presence of the indole moiety, which is often associated with activity in the central nervous system. Additionally, the sulfonyl and piperidinyl groups may contribute to its pharmacokinetic properties, enhancing its bioavailability or stability. Researchers may investigate its efficacy in modulating specific pathways or as a lead compound for further optimization in drug development programs.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :